LPA对子宫颈癌干细胞生物学特性的影响及对RhoA/Rock2通路调控作用

doi:10.3969/j.issn.1006-6233.2021.02.004

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (2419 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To study and explore the effects of lysophosphatidic acid (LPA) on the biological characteristics of cervical cancer stem cells and the regulation of RhoA/Rock2 pathway, further clarify the pathogenesis of cervical cancer and develop cervical cancer targets for the future. Point drugs provide theoretical basis. Methods: Siha cell lines were used as primary cells. The cervical cancer stem cells were cultured with balloon-encapsulated cells to observe the ability of cell colony formation. Cell surface markers were detected by FACS. After the successful cultivation of cervical cancer stem cells, they were divided into control group, LPA group and inhibition group. The control group was cultured normally. In the LPA group, LPA of different concentrations (1, 5, 10, 15, 20 umol/L) was added, and the inhibitor group was The optimal proliferative concentration of LPA cells group was based on the addition of Rho kinase inhibitor Y-27632. Cell proliferation was observed and cell growth curves were plotted. The mRNA levels of LPA, RhoA and Rock2 in each group were detected by PCR. The expression of RhoA and Rock2 was detected. Results: After culture, there were suspension cell spheres with CD44⁺, CK17⁺, CD34^- and CD105^- phenotypes. Cervical cancer stem cells were successfully obtained. After adding LPA, the proliferation of cancer cells was significantly promoted, and there was a time In a dose-dependent manner (P<0.05), addition of Y-27632 significantly inhibited cell proliferation (P<0.05). LPA, RhoA, and Rock2 mRNA levels and western blot were significantly higher in LPA group than in the control group and inhibition. Group (P<0.05). Conclusion: LPA can promote the proliferation of cervical cancer stem cells, and its mechanism of action can be achieved by regulating the RhoA/Rock2 pathway.

Key words： Lysophosphate Cervical cancer RhoA / Rock2 signaling pathway Stem cell

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHOU Yong
	LUO Baoping
	et al

Cite this article:

ZHOU Yong,LUO Baoping,et al. Effect of LPA on Biological Characteristics of Cervical Cancer Stem Cells and Regulation of RhoA/Rock2 Pathway[J]. HeBei Med, 2021, 27(2): 190-194.

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2021.02.004 OR http://www.hbyxzzs.cn/EN/Y2021/V27/I2/190

[1] 姚志峰,姚建新.长链非编码RNA在肿瘤干细胞放射耐受性中的作用[J].中华放射肿瘤学杂志,2020,29(8):699~703.
[2] Dong PP,Hao FM,Dai SF,et al. Combination therapy eve and pac to induce apoptosis in cervical cancer cells by targeting PI3K/AKT/mTOR pathways[J]. Journal of Receptors and Signal Transduction,2018,38(1):83~88.
[3] Zhang Z L,Zhu XY. Clinical significance of lysophosphatidic acid receptor-2 (LPA2) and kruppel-like factor 5 (KLF5) protein expression detected by tissue microarray in gastric adenocarcinoma.[J].Med Sci Monit,2019,5(25):4705~4715.
[4] Minami K,Ueda N,Ishimoto K,et al. Lysophosphatidic acid receptor-2 (LPA2)-mediated signaling enhances chemoresistance in melanoma cells treated with anticancer drugs. [J]. Mol Cell Biochem,2020 ,469(1~2):89~95.
[5] Guo H,Xiang Z,Zhang Y,etl. Inhibiting 6-phosphogluconate dehydrogenase enhances chemotherapy efficacy in cervical cancer via AMPK-independent inhibition of RhoA and Rac1. [J].Clin Transl Oncol,2019 ,21(4):404~411.
[6] 肖栋,段建峰,梁明,等.溶血磷脂酸受体2通过调控缺氧诱导因子-1α的表达对乳腺癌细胞转移与侵袭能力的影响[J].中华实验外科杂志,2018,35(10):1849~1851.
[7] Zhou YH,Liu Q,Da XC ,et al. Transdifferentiation of type II alveolar epithelial cells induces reactivation of dormant tumor cells by enhancing TGF-β1/SNAI2 signaling[J]. Oncol Rep,2018,39(4):1874~1882.
[8] Isabel G,Anja UB. Modulation of lysophosphatidic acid(LPA)receptor activity:the key to successful neural regeneration[J]. Neural Regen Res,2020,15(1):53~54.
[9] ChenWM,ChiangJC,LinYC,et al. Lysophosphatidic acid receptor LPA 3 prevents oxidative stress and cellular senescence in hutchinson-gilford progeria syndrome[J]. Aging Cell,2020,19(1):e13064.
[10] Hou C,Zhuang Z,Deng X,et al. Knockdown of Trio by CRISPR/Cas9 suppresses migration and invasion of cervical cancer cells[J]. Oncol Rep. 2018,39(2):795~801.
[11] Ueda H,Neyama H,Nagai J,et al. Involvement of lysophosphatidic acid-induced astrocyte activation underlying the maintenance of partial sciatic nerve injury-induced neuropathic pain[J]. PAIN,2018,159(11):2170~2178.
[12] Poirier M,Awale M,Roelli M A,et al. Front cover:Identifying lysophosphatidic acid acyltransferase β (LPAAT-β) as the target of a nanomolar angiogenesis inhibitor from a phenotypic screen using the polypharmacology browser PPB2 (Chem Med Chem 2/2019)[J]. Chemmedchem,2019,14(2):189~189.